Something old, something new combine for effective vaccine against parasitic skin disease

(Ohio State University) Scientists are planning for Phase 1 human trials of a vaccine they developed by using CRISPR gene-editing technology to mutate the parasite that causes leishmaniasis, a skin disease common in tropical regions of the world and gaining ground in the United States.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news